2020 Conference on Retroviruses and Opportunistic Infections (CROI)

8-11 March 2020

See more on the CROI website.

IMPAACT study results from 14 abstracts were presented virtually at the 2020 Conference on Retroviruses and Opportunistic Infections (CROI). Presentations will be published as permissions for posting are received. The following were presented:

Three abstracts as oral presentations (IMPAACT 2010/VESTED, IMPAACT 2003/A5300/PHOENIx, and IMPAACT 2001)

Three abstracts as posters with themed discussions (IMPAACT 2007, P1106, and A5316)

Eight abstracts as poster presentations (IMPAACT 2009, P1115, P1112, P1101, P1078, PROMISE, P1041, and laboratory analyses)

>> Download the IMPAACT at CROI 2020 Full Listing <<

Protocol

Title

Authors

Presentation Type

Monday 9 March

IMPAACT 2009

TFV-DP in DBS for Pregnant/ Postpartum Adolescent and Young Women on PrEP in Africa

Anderson P, Stranix-Chibanda L, Huang S, Hosek S, Kacanek D, Nematadzira T, Taulo F, Korutaro V, Nakabiito C, Masenya M, Lypen K, Chakhtoura N, Spiegel H, Chi BH, on behalf of the IMPAACT 2009 team

Poster Presentation
2:30 PM – 4:00 PM

P1078

Adjusted Analysis of Effect of IPT on Adverse Pregnancy Outcomes in Women with HIV

Theron G, Chakhtoura N, Montepiedra G, Aaron G, Jean-Philippe P, Weinberg A, McCarthy K, Nematadzira T, Masheto G, Chipato T, Onyango-Makumbi C, Gupta A, the IMPAACT P1078 Team

Poster Presentation
2:30 PM – 4:00 PM

Lab

Trehalose Inhibits HIV Infection in CD4+ Lymphocytes and Macrophages by Two Distinct Mechanisms

Rawat P, Hon S, Teodorof-Diedrich C, Spector SA

Poster Presentation
2:30 PM – 4:00 PM

Tuesday 10 March

IMPAACT 2007	Maraviroc Safety & Pharmacokinetics in HIV-exposed Neonates Poster Themed Discussion	Rosebush J, Best B, Chadwick E, Moye J, Smith E, Butler K, Bradford S, Whitson K, Mathiba SR, Hanley S, Aziz M, Hayward K, Mirochnick M, Samson P, for the IMPAACT 2007 Study Team	Themed Discussion 1:30 PM – 2:30 PM Poster Presentation 2:30 PM – 4:00 PM
P1106	Abacavir Safety and Pharmacokinetics in Normal and Low Birth Weight Infants with HIV	Cressey TR, Bekker A, Cababasay M, Wang J, Moye J, Violari A, Cotton M, Wiesner L, Rabie H, Mirochnick M, Capparelli E, IMPAACT P1106 team	Themed Discussion 1:30 PM – 2:30 PM Poster Presentation 2:30 PM – 4:00 PM
A5316	A Combined Estrogen/Progestin Vaginal Ring Improves Vaginal Microbial Communities	Tobin NH, Brooker S, Li F, Cramer YS, Rosenkranz S, Aldrovandi GM, Coombs R, Cohn S, Zorrilla C, Moran L, Berzins B, Scarsi KK, Godfrey C, for the ACTG 5316 Team	Poster Presentation (10 March) 2:30 PM – 4:00 PM Themed Discussion (11 March) 1:30 PM – 2:30 PM
DR 808 (P1112, P1115, PACTG230, PACTG326)	Cost-effectiveness of Broadly Neutralizing Antibodies for Infant HIV Prophylaxis	Dugdale CM, Permar SR, Stranix-Chibanda L, Walensky RP, Fouda GG, Myer L, Cunningham CK, Weinstein MC, Leroy V, McFarland EJ, Freedberg KA, and Ciaranello AL	Poster Presentation 2:30 PM – 4:00 PM
P1101	Pharmacokinetics of Raltegravir in HIV/TB Co-Treated Infants and Young Children	Krogstad P, Samson P, Acosta E, Moye J, Townley E, Bradford S, Brown E, Graham B, Hovind L, Teppler H, Mathiba SR, Masebole M, Cotton M, Winckler J, Meyers T	Poster Presentation 2:30 PM – 4:00 PM

Wednesday 11 March

IMPAACT 2010	Safety and Efficacy of DTG vs EFV and TDF vs TAF in Pregnancy: IMPAACT 2010 Trial	Chinula L, Brummel S, Ziemba L, Stranix-Chibanda L, Coletti A, Krotje C, Jean-Philippe P, Fairlie L, Vhembo T, Wabwire D, Hoffman R, Sax P, Stringer J, Currier J, Lockman S	Oral Presentation 10:00 AM – 12:00 PM
IMPAACT 2001	Rifapentine Pharmacokinetics and Safety in Pregnant Women with and without HIV on 3HP	Mathad JS, Savic R, Britto P, Wiesner L, Townley E, Chakhtoura N, Bradford S, Patil S, Vhembo T, Lespinasse D, Langat D, Werarak P, Kamthunzi P, Gupta A, Dooley KE	Oral Presentation 10:00 AM – 12:00 PM
A5300/IMPAACT 2003	Predictors of Tuberculosis Infection in MDR-TB Household Contacts ≥15 years old	Kim S, Gupta A, Wu X, Hughes M, Dawson R, Mave V, Kumarasamy N, Smith B, Rustomgee R, Shah NS, Hesseling A, Swindells S, Churchyard G, ACTG/IMPAACT A5300/I2003 PHOENIx Feasibility Study Team	Oral Presentation 10:00 AM – 12:00 PM
Lab	HIV Exposure and Human Milk Oligosaccharides Modulate the Infant Gut Microbiota	Brooker SL, Tobin NH, Li F, Kuhn L, Aldrovandi GM	Poster Presentation 2:30 PM – 4:00 PM
NWCS 619 (PROMISE)	Metabolites, Preterm Labor and Antiretroviral Therapy	Tobin NH, Murphy A, Li F, Brummel S, Fowler MG, McIntyre J, Currier JS, Chipato T, Flynn P, Koos B, Aldrovandi GM, and the PROMISE team	Poster Presentation 2:30 PM – 4:00 PM
P1041	Evaluation of a Blood-based Antigen Test for Tuberculosis in Infants	Mao L, LaCourse SM, Kim S, Liu C, Jiao W, Lyon CJ, Nachman S, Mitchell CD, Hu Y	Poster Presentation 2:30 PM – 4:00 PM